First Administration of the Fc-Attenuated Anti-β Amyloid Antibody GSK933776 to Patients with Mild Alzheimer's Disease: A Randomized, Placebo-Controlled Study.
(2015) In PLoS ONE 10(3).- Abstract
- To assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the Fc-inactivated anti-β amyloid (Aβ) monoclonal antibody (mAb) GSK933776 in patients with mild Alzheimer's disease (AD) or mild cognitive impairment (MCI).
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/5258076
- author
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- PLoS ONE
- volume
- 10
- issue
- 3
- article number
- e0098153
- publisher
- Public Library of Science (PLoS)
- external identifiers
-
- pmid:25789616
- wos:000351425400001
- scopus:84961291985
- pmid:25789616
- ISSN
- 1932-6203
- DOI
- 10.1371/journal.pone.0098153
- language
- English
- LU publication?
- yes
- id
- 7ac14423-2cf8-4c69-b486-d2a6f7c68a01 (old id 5258076)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25789616?dopt=Abstract
- date added to LUP
- 2016-04-01 13:21:49
- date last changed
- 2022-04-21 21:14:06
@article{7ac14423-2cf8-4c69-b486-d2a6f7c68a01, abstract = {{To assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the Fc-inactivated anti-β amyloid (Aβ) monoclonal antibody (mAb) GSK933776 in patients with mild Alzheimer's disease (AD) or mild cognitive impairment (MCI).}}, author = {{Andreasen, Niels and Simeoni, Monica and Östlund, Henrik and Lisjo, Pia I and Fladby, Tormod and Loercher, Amy E and Byrne, Gerard J and Murray, Frances and Scott-Stevens, Paul T and Wallin, Anders and Zhang, Yinghua Y and Bronge, Lena H and Zetterberg, Henrik and Nordberg, Agneta K and Yeo, Astrid J and Khan, Shahid A and Hilpert, Jan and Mistry, Prafull C}}, issn = {{1932-6203}}, language = {{eng}}, number = {{3}}, publisher = {{Public Library of Science (PLoS)}}, series = {{PLoS ONE}}, title = {{First Administration of the Fc-Attenuated Anti-β Amyloid Antibody GSK933776 to Patients with Mild Alzheimer's Disease: A Randomized, Placebo-Controlled Study.}}, url = {{http://dx.doi.org/10.1371/journal.pone.0098153}}, doi = {{10.1371/journal.pone.0098153}}, volume = {{10}}, year = {{2015}}, }